Volume 61, Issue 6, Pages (June 2012)

Slides:

Advertisements

Similar presentations

The GOLIATH Study ..

Advertisements

1 GreenLight XPS™ Laser Therapy System The GOLIATH Study.

Volume 42, Issue 1, Pages 7-11 (July 2002)

Volume 50, Issue 3, Pages (September 2006)

Economic Value of the Transurethral Resection in Saline System for Treatment of Benign Prostatic Hyperplasia in England and Wales: Systematic Review,

Volume 71, Issue 2, Pages (February 2017)

Volume 59, Issue 2, Pages (February 2011)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 4, Pages (October 2010)

Management of Acute and Chronic Retention in Men

Volume 54, Issue 6, Pages (December 2008)

Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Steven A. Kaplan,

Volume 64, Issue 1, Pages (July 2013)

Volume 191, Issue 1, Pages (January 2014)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 52, Issue 1, Pages (July 2007)

Volume 59, Issue 4, Pages (April 2011)

Volume 52, Issue 2, Pages (August 2007)

Let the Games Begin (with EAU Approval)

Volume 71, Issue 2, Pages (February 2017)

Prostate Cancer Epidemic in Sight?

Rowland Illing European Urology Supplements

Volume 64, Issue 3, Pages (September 2013)

Volume 53, Issue 2, Pages (February 2008)

Volume 55, Issue 2, Pages (February 2009)

The Long-Term Outcome of Medical Therapy for BPH

Volume 46, Issue 4, Pages (October 2004)

Volume 63, Issue 1, Pages (January 2013)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Raymond C. Rosen, Francois Giuliano, Culley.

Volume 52, Issue 3, Pages (September 2007)

Rowland Illing European Urology Supplements

Volume 64, Issue 4, Pages (October 2013)

Volume 60, Issue 1, Pages (July 2011)

Volume 58, Issue 3, Pages (September 2010)

Volume 60, Issue 4, Pages (October 2011)

Volume 61, Issue 3, Pages (March 2012)

Volume 68, Issue 4, Pages (October 2015)

Prostate Cancer Epidemic in Sight?

Volume 64, Issue 2, Pages (August 2013)

Yuanshan Cui, Yong Zhang European Urology

Volume 71, Issue 4, Pages (April 2017)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old P. Perrin,

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 65, Issue 5, Pages (May 2014)

Classification of Male Lower Urinary Tract Symptoms Using Mathematical Modelling and a Regression Tree Algorithm of Noninvasive Near-Infrared Spectroscopy.

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

Volume 50, Issue 3, Pages (September 2006)

Volume 50, Issue 5, Pages (November 2006)

Volume 46, Issue 5, Pages (November 2004)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Transurethral Resection of the Prostate

Testicular Cancer Variations in Time and Space in Europe

Volume 54, Issue 6, Pages (December 2008)

Volume 52, Issue 6, Pages (December 2007)

When to Treat the Prostate, the Bladder, or Both?

Volume 53, Issue 6, Pages (June 2008)

European Urology is “Your” Journal

Emmanuel Chartier-Kastler, Kate Davidson European Urology Supplements

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Martin Michel, Jean de la Rosette European Urology Supplements

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia? Vincenzo Mirone

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

Vassilios Tzortzis, Stavros Gravas, Jean J.M.C.H. de la Rosette

Presentation transcript:

Volume 61, Issue 6, Pages 1165-1173 (June 2012) Photoselective Vaporization of the Prostate with GreenLight 120-W Laser Compared with Monopolar Transurethral Resection of the Prostate: A Multicenter Randomized Controlled Trial Bertrand Lukacs, Joyce Loeffler, Franck Bruyère, Pascal Blanchet, Albert Gelet, Patrick Coloby, Alexandre De la Taille, Philippe Lemaire, Jean-Christophe Baron, Jean-Nicolas Cornu, Mounir Aout, Helene Rousseau, Eric Vicaut European Urology Volume 61, Issue 6, Pages 1165-1173 (June 2012) DOI: 10.1016/j.eururo.2012.01.052 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 One-month questionnaire for urinary tract symptoms after endoscopic surgery of the prostate. European Urology 2012 61, 1165-1173DOI: (10.1016/j.eururo.2012.01.052) Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 2 Study flowchart. Data concerning dropouts were analyzed with the last observation carried forward method. PVP=photoselective vaporization of the prostate; TURP=transurethral resection of the prostate. European Urology 2012 61, 1165-1173DOI: (10.1016/j.eururo.2012.01.052) Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 3 Box plot graphs showing evolution of the urinary parameters during follow-up (data are given as median and interquartile range). (A) Evolution of International Prostate Symptom Score (IPSS); (B) evolution of maximum flow rate (Qmax) in milliliters per second; (C) evolution of postvoiding residual (PVR) in milliliters. PVP=photoselective vaporization of the prostate; TURP=transurethral resection of the prostate. European Urology 2012 61, 1165-1173DOI: (10.1016/j.eururo.2012.01.052) Copyright © 2012 European Association of Urology Terms and Conditions